Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
autologous lymphocytes (1 trial)
autologous T cell memory cells (2 trials)
NWRD06 (1 trial)
nwrd08 (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Cholangiocarcinoma (Phase 2)
Trials (5 total)
Trial APIs (4 total)